Joseph Eid | SVP
Bristol Myers Squibb

Joseph Eid, SVP, Bristol Myers Squibb

Dr. Joseph Eid is a physician, board certified in Medical Oncology, Hematology, and Internal Medicine. He joined BMS in 2017 as Senior Vice President and Head of Medical.
Before joining BMS, Joe worked at Merck in Oncology Clinical Research, and in this capacity he was the team leader for Pembrolizumab (anti-PD-1 antibody) from first in man trial leading to registration. 
Prior to joining Merck, Joe was at Roche Pharmaceuticals in Oncology Clinical Research. 
Joe received his medical degree from St. Joseph University School of Medicine in Beirut, Lebanon.  He completed his fellowship in hematology and medical oncology at Rutgers-Robert Wood Johnson Medical School (RWJMS).  He was recruited to the faculty at RWJMS and appointed Assistant Professor of Medicine and Pathology, Departments of Medicine and Pathology and Laboratory Medicine.  Joe is a licensed physician in New Jersey and continues to attend a weekly, half-day clinic at RWJMS.


World Immunotherapy Congress 2018, Day 1 @ 09:20

Precision medicine in the era of immunotherapy

  • Why do we need new biomarkers?
  • Is tumor mutation burden the better single marker?
  • Do we need a multiparameter biomarker analyses or composite biomarker?
  • What are some potential new biomarkers?

World Immunotherapy Congress 2018, Day 1 @ 11:35

Plenary round table session

Table 4: Precision medicine in the era of Immunotherapy

last published: 29/Oct/18 16:25 GMT
last published: 29/Oct/18 16:25 GMT

back to speakers

There are two parts to the Festival of Biologics: the five world-class international conferences covering Antibodies, Immunotherapy, BioSimilars, Clinical Trials, and High Potency APIs; and an exhibition featuring the most exciting technology and solutions for pharma and biotech. There is a registration fee to attend the conferences. To visit the exhibition is free.


Conference 29 - 31 October • Exhibition & Seminars 29 - 31 October

Sign Up for Event Updates